Lv1
40 积分 2023-10-30 加入
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
13天前
已完结
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
1个月前
已完结
Epidemiology and genomics of prostate cancer in Asian men
1个月前
已完结
Fatty acid diet and prostate cancer: a treasure hunt or a wild goose chase?
1个月前
已完结
Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy
1个月前
已完结
PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer
4个月前
已完结
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
4个月前
已完结
PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret?
4个月前
已完结
Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis
4个月前
已完结
Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test
5个月前
已完结
皖公网安备34019202002308
